INOTIV INC. - COMMON
1.8500
07-十月-24 14:59:59
15 分钟延时
股票
-0.0750
-3.90%
今日范围
1.8350 - 1.9200
ISIN
N/A
来源
NASDAQ
-
07 12月 2021 15:03:00 条件 Nasdaq GlobeNewswire
-
29 11月 2021 15:21:00 条件 Nasdaq GlobeNewswire
-
Inotiv, Inc. Announces Opening of Newly-Constructed Laboratories at St. Louis Facility
10 11月 2021 07:33:00 条件 Nasdaq GlobeNewswire
-
Inotiv, Inc. Completes Purchase of Envigo
05 11月 2021 12:33:34 条件 Nasdaq GlobeNewswire
-
Inotiv, Inc. Shareholders Approve Acquisition of Envigo
04 11月 2021 11:00:00 条件 Nasdaq GlobeNewswire
-
Inotiv, Inc. to Participate in Upcoming Investor Conferences
02 11月 2021 16:34:47 条件 Nasdaq GlobeNewswire
-
04 10月 2021 15:05:00 条件 Nasdaq GlobeNewswire
-
27 9月 2021 15:05:00 条件 Nasdaq GlobeNewswire
-
Inotiv, Inc. Prices Upsized $125 Million Convertible Senior Notes Offering
22 9月 2021 17:34:29 条件 Nasdaq GlobeNewswire
-
Inotiv, Inc. Announces Proposed Convertible Senior Notes Offering
21 9月 2021 16:05:00 条件 Nasdaq GlobeNewswire
-
Inotiv, Inc. and Envigo Propose to Join Forces to Enhance Research and Drug Discovery Solutions
21 9月 2021 08:00:02 条件 Nasdaq GlobeNewswire
-
Inotiv, Inc. to Participate in the 2021 Colliers Institutional Investor Conference
31 8月 2021 15:05:00 条件 Nasdaq GlobeNewswire
-
Inotiv, Inc. Announces Third Quarter Fiscal 2021 Financial Results
11 8月 2021 15:05:01 条件 Nasdaq GlobeNewswire
-
Inotiv, Inc. Announces Acquisition of Gateway Pharmacology Laboratories
02 8月 2021 11:15:00 条件 Nasdaq GlobeNewswire
-
22 7月 2021 15:05:01 条件 Nasdaq GlobeNewswire
-
Inotiv Acquires Laboratory Instrumentation for Discovery and Development of Novel Therapies
15 7月 2021 07:33:00 条件 Nasdaq GlobeNewswire
-
Inotiv Acquires Genetic Toxicology Assets from MilliporeSigma’s BioReliance® portfolio
12 7月 2021 07:33:00 条件 Nasdaq GlobeNewswire
-
28 6月 2021 07:33:00 条件 Nasdaq GlobeNewswire
-
Inotiv Set to Join Russell 3000® Index and Russell 2000® Index
07 6月 2021 15:15:00 条件 Nasdaq GlobeNewswire
-
Inotiv Announces Purchase of St. Louis Facility and Plans to Expand Capacity
27 5月 2021 07:33:00 条件 Nasdaq GlobeNewswire